Evidence map›Paper›PMID 34964423›Full record

ArticleDrug delivery2022

The efficacy of

Dina B E Farag, Carol Yousry, Abdulaziz Mohsen Al-Mahallawi, Hesham I El-Askary, Meselhy R Meselhy, Nermeen AbuBakr

Abstract read
In one paragraph

Article in Drug delivery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. White saffron (Toxicology reports · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dina B E FaragDepartment of Oral Biology, Faculty of Dentistry, Cairo University, Cairo, Egypt.ORCID 0000-0002-8856-8906
Carol YousryDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.ORCID 0000-0002-7593-6001
Abdulaziz Mohsen Al-MahallawiDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.ORCID 0000-0003-1694-1342
Hesham I El-AskaryDepartment of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.ORCID 0000-0001-7764-6588
Meselhy R MeselhyDepartment of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.ORCID 0000-0002-3488-7522
Nermeen AbuBakrDepartment of Oral Biology, Faculty of Dentistry, Cairo University, Cairo, Egypt.ORCID 0000-0003-2962-0070

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus is a challenging health problem. Salivary gland dysfunction is one of its complications. Current treatments possess numerous adverse effects. Therefore, herbal extracts have emerged as a promising approach for safe and effective treatment. However, they are required in large doses to achieve the desired effect. Accordingly,

Indexed as

OriganumAnimalsBlood GlucoseChemistry, PharmaceuticalDiabetes Mellitus, ExperimentalDrug CarriersKelch-Like ECH-Associated Protein 1MaleNanostructuresNF-E2-Related Factor 2p38 Mitogen-Activated Protein KinasesParticle SizePlant ExtractsRandom AllocationRatsStreptozocinBlood GlucoseDrug CarriersKEAP1 protein, humanKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2p38 Mitogen-Activated Protein KinasesPlant ExtractsStreptozocincubosomal nano-vesiclesDiabetes mellitusHPLC standardizationOriganum majoranarosmarinic acidsalivary glands

Identifiers

PMID34964423
PMCPMC8725878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.